A cross-sectional and retrospective chart review study was conducted at the Princess Mother National Institute on Drug Abuse Treatment (PMNIDAT), Thailand. All patients who admitted at PMNIDAT from October 2013 to September 2019 were included. Patients aged 18-65 years who met the International Classification of Disease-10 (ICD-10) criteria of CIP and Had a positive urine test of cannabis were included. Cannabis use is a component cause of psychosis.More than half of symptoms of cannabis-induced psychosis (CIP) were hallucination, delusion, irritable and anxiety. Antipsychotic drug was still a key psychotropic drugs for treatment of CIP. However, antidepressants and benzodiazepines were commonly used for treatment of other symptoms beyond psychotics
Study Type
OBSERVATIONAL
Enrollment
317
This study is observational study, we recorded history of substance used, symptoms and medication in a medical chart.
Onrumpha Chuenchom
Thanyaburi, Changwat Pathum Thani, Thailand
Pharmacological treatment pattern for cannabis-induced psychosis
Pharmacological treatment pattern for cannabis-induced psychosis during admission
Time frame: 30 days
Change of Brief psychiatric rating scale (BPRS) form the first day of admission
A high BPRS score is more severe of symptoms than a lower score
Time frame: Day1, Day 8, Day 15 and Day 22
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.